Maryland Senate Bill SB716

Maryland 2024 Regular Session

• Introduced: 1/31/24
• Refer: 1/31/24

Caption

Maryland Medical Assistance Program - Maternal Fetal Medicine Services - Reimbursement

Impact

The enactment of SB716 will significantly enhance the reimbursement structure for maternal fetal medicine services under Maryland's Medical Assistance Program. By aligning state reimbursements with Medicare rates, the bill is intended to improve access to specialized care for high-risk pregnant patients. This alignment is also expected to encourage healthcare providers to offer essential services related to maternal and fetal health without facing financial constraints, ultimately helping to reduce health disparities among vulnerable populations.

Summary

Senate Bill 716, introduced by Senator Hettleman, aims to amend the Maryland Medical Assistance Program by ensuring that physicians billing for maternal fetal medicine services receive reimbursement at rates consistent with the federal Medicare fee schedule. The bill specifically includes provisions for reimbursement associated with certain procedural codes relevant to maternal fetal medicine. It emphasizes the financial support for care provided to patients experiencing high-risk pregnancies, which could encompass various medical conditions including diabetes, hypertension, and multiple gestations.

Contention

While the bill is primarily focused on improving healthcare access, it may face scrutiny regarding the adequacy of funding and the administrative processes required for implementing the new reimbursement structure. Lawmakers and health advocates are likely to discuss whether the alignment with Medicare rates is sustainable or sufficient to meet the needs of all service providers and pregnant patients. Furthermore, potential opposition could arise from stakeholders who fear that increased reimbursement rates might inadvertently lead to overutilization of services, placing additional strain on the state’s Medical Assistance budget.